Haemoadsorption in infective endocarditis: a systematic review.

Cardiac surgery CytoSorb® Haemoadsorption Infective endocarditis

Journal

Indian journal of thoracic and cardiovascular surgery
ISSN: 0970-9134
Titre abrégé: Indian J Thorac Cardiovasc Surg
Pays: India
ID NLM: 8700105

Informations de publication

Date de publication:
May 2024
Historique:
received: 27 12 2023
revised: 24 01 2024
accepted: 24 01 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: ppublish

Résumé

Infective endocarditis surgical patients suffer from high rates of severe complications such as systemic inflammatory response, septic shock, and multi-organ failure leading to high mortality. Systemic inflammatory response based on cytokines as messengers plays an important role in these patients. The concept of intraoperative haemoadsorption has been proposed to remove such elevated cytokines in patients undergoing cardiac surgery for infective endocarditis. Haemoadsorption offers the possibility to stabilise haemodynamics, reduce sepsis-related mortality, and protect organ function. However, until now, there has been no general opinion and consensus regarding the clinical effectiveness of adjunctive intraoperative haemoadsorption in infective endocarditis. Therefore, we reviewed the current literature evaluating haemoadsorption in infective endocarditis patients undergoing cardiac surgery. The review was registered at PROSPERO (CRD42023457632). The online version contains supplementary material available at 10.1007/s12055-024-01701-0.

Identifiants

pubmed: 38827548
doi: 10.1007/s12055-024-01701-0
pii: 1701
pmc: PMC11139808
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

69-77

Informations de copyright

© The Author(s) 2024.

Déclaration de conflit d'intérêts

Conflict of interestMT, CB, and GL received speaker honoraria and travel fees from CytoSorbents Europe GmbH; DW is a full-time employee of CytoSorbents Europe GmbH.

Auteurs

Matthias Thielmann (M)

Department of Thoracic and Cardiovascular Surgery, West German Heart & Vascular Center Essen, Hufelandstr. 55, 45122 Essen, Germany.

Daniel-Sebastian Dohle (DS)

University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Martin Czerny (M)

Department of Cardiovascular Surgery, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nikolaos Bonaros (N)

Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Daniel Wendt (D)

Department of Thoracic and Cardiovascular Surgery, West German Heart & Vascular Center Essen, Hufelandstr. 55, 45122 Essen, Germany.
CytoSorbents Europe GmbH, Berlin, Germany.

Thierry Folliguet (T)

Department of Cardiac Surgery, Henri Mondor Hospital, Paris, France.

Christophe Baufreton (C)

Department of Cardiovascular and Thoracic Surgery, University Hospital, Angers, France.

Guillaume Lebreton (G)

Department of Thoracic and Cardiovascular Surgery, Pitié-Salpêtrière University Hospital, Paris, France.

Classifications MeSH